PMID: 20120390Feb 3, 2010Paper

Polyneuropathy associated with monoclonal gammapathy: treatment perspectives

Bulletin de l'Académie nationale de médecine
Jean-Marc LegerJ Neil

Abstract

Since the first report of a high prevalence of monoclonal gammapathy (MG) in patients with peripheral neuropathy (PN), some 25 years ago, a large number of such associations have been described. Neuropathies associated with MG have heterogeneous clinical, neurophysiological, neuropathological, and hematological features. The most pertinent relationship seems to be that between distal acquired demyelinating sensory (DADS) neuropathy associated with IgM MG of unknown significance (MGUS) and the presence of serum autoantibodies reacting with myelin-associated glycoprotein (MAG). Other interesting correlations were recently reported in CANOMAD (chronic ataxic neuropathy with ophthalmoplegia, M-protein and anti-disialosyl antibodies). Patients with demyelinating neuropathy (DNP) associated with MG should be screened for malignant plasma cell dyscrasia. MG is more likely to be responsible for the neuropathy if it consists of IgM, if autoantibodies (mainly directed to MAG) are found in serum or on nerve biopsy, and if the clinical manifestations correspond to chronic distal sensory neuropathy. DNP associated with IgM MGUS sometimes responds to immunotherapy but the potential benefits must be considered in view of possible adverse effe...Continue Reading

Related Concepts

Related Feeds

Amyloidogenesis-associated Polyneuropathy

Amyloid deposits around nerves can damage and disrupt smooth information processing between the brain and organs. Here is the latest research on amyloidosis-associated polyneuropathies.

Related Papers

Nihon rinsho. Japanese journal of clinical medicine
T Saito
European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
Y A Rajabally
Journal of Neurology, Neurosurgery, and Psychiatry
Michelle L MauermannP James B Dyck
© 2021 Meta ULC. All rights reserved